National ICD Registry Proposal Critiqued By Manufacturers, ACC/HRS
This article was originally published in The Gray Sheet
Executive Summary
CMS' implantable cardioverter defibrillator registry should limit its initial scope to follow-up data at the time of re-hospitalization to keep expenses manageable, according to ICD manufacturers and professional societies
You may also be interested in...
CMS Expands ICD Coverage In Long-Awaited Decision; Stakeholders Rejoice
CMS' expansion of implantable cardioverter defibrillator Medicare coverage incorporates several recommendations from manufacturers and professional societies
CMS Expands ICD Coverage In Long-Awaited Decision; Stakeholders Rejoice
CMS' expansion of implantable cardioverter defibrillator Medicare coverage incorporates several recommendations from manufacturers and professional societies
ICD Coverage Saga Reaches Dénouement With SCD-HeFT Study Publication
CMS says it likely will issue a final ICD coverage decision Jan. 26, with the publication of Medtronic's SCD-HeFT study in the New England Journal of Medicine.